<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002583'>Colitis</z:hpo> is the term used for <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel diseases</z:e> at substantially increased risk of developing a form of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) known as <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In our study we synthesized core-shell polymeric micelles obtained by self-assembly of <z:chebi fb="6" ids="53511">block copolymers</z:chebi> for high efficiency delivery of anti-inflammatory and anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> compounds to colonocytes and colon mucosa </plain></SENT>
<SENT sid="2" pm="."><plain>We achieved an efficient intracellular delivery of these hydrophobic compounds (<z:chebi fb="0" ids="8382">prednisone</z:chebi>, <z:chebi fb="2" ids="26536">retinoic acid</z:chebi> and <z:chebi fb="0" ids="28748">doxorubicin</z:chebi>) to cultured colonocytes without cellular toxicity </plain></SENT>
<SENT sid="3" pm="."><plain>The efficacy of <z:chebi fb="2" ids="26536">retinoic acid</z:chebi> and <z:chebi fb="0" ids="28748">doxorubicin</z:chebi> administration was significantly increased using these nanosized carriers </plain></SENT>
<SENT sid="4" pm="."><plain>Moreover, these polymeric micelles have been shown to overcome the multidrug resistance efflux mechanism effectively delivering <z:chebi fb="0" ids="28748">doxorubicin</z:chebi> to multidrug-resistant <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells </plain></SENT>
<SENT sid="5" pm="."><plain>These nanocarriers are also suitable for selective in vivo delivery of lipophilic drugs by enema administration to the inflamed colon tissue, specifically targeting the inflamed mucosa </plain></SENT>
</text></document>